TSJCI Annual Report 2021

Trinity St James’s Cancer Institute Annual Report 2021 18 Section 1.11 Pharmacy 1.11.1 Key Developments during 2021 National Cancer Information System (NCIS) • The Pharmacy team worked alongside nursing, oncology & haematology on the implementation programme for the electronic prescribing, manufacture and administration of anti-cancer treatments on NCIS. • NCIS launched in December 2021 with NCIS workflows successfully incorporated into the Aseptic Compounding unit and 50% of anti-cancer treatments prescribed and administered electronically. CAR T Therapy • The Pharmacy Dept. supported the planning leading up to the implementation of CAR T therapy in December 2021. The pharmacy role in CAR T therapy includes procurement, product receipt and release in liaison with the Cryobiology Lab & practical aspects of clinical pharmacy and medicines management. SJH Medicines Guide • During 2021 the Pharmacy Clinical Services team replaced the Hospital Prescribers Guide with a new Medicines Guide that facilitated mobile application and desktop access across the hospital. 1.11.2 Key Priorities for 2022 Chemotherapy Compounding Robot • To develop the specification to support procurement of a chemotherapy compounding robot. • This will enable the procurement process to commence with a target implementation in 2023. National Cancer Information System (NCIS) • To continue to embed the NCIS implementation including extending the range of anti- cancer treatment regimens available electronically.